Larid, Guillaume http://orcid.org/0000-0003-2317-2852
Baudens, Guy
Tiemdjo-Djimaffo, Georges
Coquerelle, Pascal
Goeb, Vincent
Guyot, Marie Hélène
Marguerie, Laurent
Maury, Frédéric
Veillard, Eric
Houvenagel, Eric
Salmon, Jean-Hugues
Flipo, René-Marc
Gervais, Elisabeth http://orcid.org/0000-0003-3513-2989
Funding for this research was provided by:
MSD France
Article History
Received: 8 July 2022
Accepted: 12 January 2024
First Online: 16 January 2024
Competing interests
: GL: NOVARTIS, GSK, AMGEN VG: MSD, UCB, Pfizer, Sanofi , novartis, Abbvie, Medac JHS: AbbVie, BMS, Galapagos, Janssen, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi, UCB, Viatris RMF: Abbvie, Pfizer, MSD, Celltrion EG: BMS, Sanofi-Aventis, Roche, Abbvie, Novartis, Pfizer, Galapagos, MSD, Janssen FM, GB, GTD, PQ, EH, EV, LM, MHG had no competing interest.